Garcia Vidal, CarolinaViasus, DiegoCarratalà, Jordi2020-04-242020-04-242012-07-260028-4793https://hdl.handle.net/2445/157357To the Editor: Wenzel and colleagues (July 26 issue) recommend long-term azithromycin for a 55-year-old man with recurrent exacerbations of chronic obstructive pulmonary disease (COPD), a forced expiratory volume in 1 second (FEV1) of 50% of the predicted value, dyspnea, cough, and sputum production. However, before azithromycin, we think this patient should be treated with other pharmacologic agents to manage his COPD and prevent exacerbations.8 p.application/pdfeng(c) Massachusetts Medical Society, 2012Antígens bacteriansÚs terapèuticMalalties del pulmóBacterial antigensTherapeutic usePulmonary diseasesinfo:eu-repo/semantics/article6175102020-04-24info:eu-repo/semantics/openAccess22830464